19-13317310-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001127222.2(CACNA1A):​c.1357G>A​(p.Ala453Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00502 in 1,600,748 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A453S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0043 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0051 ( 27 hom. )

Consequence

CACNA1A
NM_001127222.2 missense

Scores

2
10
5

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 4.13

Publications

23 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009932339).
BP6
Variant 19-13317310-C-T is Benign according to our data. Variant chr19-13317310-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 68420.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00425 (647/152144) while in subpopulation NFE AF = 0.00544 (370/68008). AF 95% confidence interval is 0.00498. There are 5 homozygotes in GnomAd4. There are 347 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 647 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001127222.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1A
NM_001127222.2
MANE Select
c.1357G>Ap.Ala453Thr
missense
Exon 11 of 47NP_001120694.1O00555-8
CACNA1A
NM_001127221.2
MANE Plus Clinical
c.1360G>Ap.Ala454Thr
missense
Exon 11 of 47NP_001120693.1O00555-3
CACNA1A
NM_023035.3
c.1360G>Ap.Ala454Thr
missense
Exon 11 of 48NP_075461.2A0A087WW63

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1A
ENST00000360228.11
TSL:1 MANE Select
c.1357G>Ap.Ala453Thr
missense
Exon 11 of 47ENSP00000353362.5O00555-8
CACNA1A
ENST00000638009.2
TSL:1 MANE Plus Clinical
c.1360G>Ap.Ala454Thr
missense
Exon 11 of 47ENSP00000489913.1O00555-3
CACNA1A
ENST00000638029.1
TSL:5
c.1360G>Ap.Ala454Thr
missense
Exon 11 of 48ENSP00000489829.1A0A087WW63

Frequencies

GnomAD3 genomes
AF:
0.00426
AC:
647
AN:
152026
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000870
Gnomad AMI
AF:
0.0373
Gnomad AMR
AF:
0.000852
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.0174
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00544
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00447
AC:
1108
AN:
247928
AF XY:
0.00431
show subpopulations
Gnomad AFR exome
AF:
0.000653
Gnomad AMR exome
AF:
0.00114
Gnomad ASJ exome
AF:
0.000400
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0185
Gnomad NFE exome
AF:
0.00534
Gnomad OTH exome
AF:
0.00600
GnomAD4 exome
AF:
0.00510
AC:
7391
AN:
1448604
Hom.:
27
Cov.:
31
AF XY:
0.00492
AC XY:
3532
AN XY:
717536
show subpopulations
African (AFR)
AF:
0.000751
AC:
25
AN:
33278
American (AMR)
AF:
0.00106
AC:
47
AN:
44448
Ashkenazi Jewish (ASJ)
AF:
0.000346
AC:
9
AN:
25990
East Asian (EAS)
AF:
0.0000254
AC:
1
AN:
39336
South Asian (SAS)
AF:
0.000722
AC:
62
AN:
85898
European-Finnish (FIN)
AF:
0.0187
AC:
994
AN:
53238
Middle Eastern (MID)
AF:
0.000881
AC:
5
AN:
5674
European-Non Finnish (NFE)
AF:
0.00547
AC:
6022
AN:
1100998
Other (OTH)
AF:
0.00378
AC:
226
AN:
59744
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
325
651
976
1302
1627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
216
432
648
864
1080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00425
AC:
647
AN:
152144
Hom.:
5
Cov.:
32
AF XY:
0.00467
AC XY:
347
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.000867
AC:
36
AN:
41502
American (AMR)
AF:
0.000851
AC:
13
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4810
European-Finnish (FIN)
AF:
0.0174
AC:
184
AN:
10576
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00544
AC:
370
AN:
68008
Other (OTH)
AF:
0.00378
AC:
8
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
32
63
95
126
158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00464
Hom.:
7
Bravo
AF:
0.00319
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00467
AC:
18
ESP6500AA
AF:
0.00106
AC:
4
ESP6500EA
AF:
0.00570
AC:
47
ExAC
AF:
0.00440
AC:
532
EpiCase
AF:
0.00453
EpiControl
AF:
0.00333

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not provided (6)
-
-
4
not specified (4)
-
-
1
CACNA1A-related disorder (1)
-
-
1
Episodic ataxia type 2 (1)
-
-
1
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Spinocerebellar ataxia type 6;C1720416:Episodic ataxia type 2;C1832884:Migraine, familial hemiplegic, 1;C4310716:Developmental and epileptic encephalopathy, 42 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.69
BayesDel_addAF
Uncertain
0.049
T
BayesDel_noAF
Pathogenic
0.30
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.059
T
Eigen
Uncertain
0.45
Eigen_PC
Uncertain
0.50
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.91
D
MetaRNN
Benign
0.0099
T
MetaSVM
Uncertain
0.26
D
MutationAssessor
Benign
1.6
L
PhyloP100
4.1
PrimateAI
Uncertain
0.67
T
PROVEAN
Uncertain
-2.8
D
REVEL
Uncertain
0.56
Sift
Benign
0.34
T
Sift4G
Benign
0.082
T
Vest4
0.55
MVP
0.97
MPC
2.2
ClinPred
0.031
T
GERP RS
5.6
Varity_R
0.27
gMVP
0.70
Mutation Taster
=32/68
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41276886; hg19: chr19-13428124; COSMIC: COSV64202206; COSMIC: COSV64202206; API